20-F: FY2023 Annual Report
6-K: Report of foreign private issuer (related to financial reporting)
EUDA Health Holdings Limited Has Received Nasdaq Notification Regarding Minimum Market Value Deficiency
8i Acquisition 2 Corp. Announces Approval of Business Combination and Ability of Shareholders to Withdraw Ordinary Shares Tendered for Redemption
8i Acquisition 2 Corp. and EUDA Health Limited Announce Amendment to Share Purchase Agreement
8i Acquisition 2 Corp. and EUDA Health Limited Announce Extension of Due Diligence Review Period